Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The 2008T BlueStar Hemodialysis Machine is indicated for acute and chronic dialysis therapy in a healthcare facility. Additional therapy options for patients receiving hemodialysis include: Isolated Ultrafiltration, Sustained Low Efficiency Dialysis (SLED), and low volume hemodialysis (patients weighing ≥ 20 kg). This machine accommodates the use of both low flux and high flux dialyzers. The SLED therapy option is not to be used for patients weighing ≤ 40 kg. The 2008T BlueStar Hemodialysis Machine is not to be used for plasma replacement therapies, for patients weighing less than 20 kg, or for renal therapies using substitution fluid.

    bibag System (Optional):

    The bibag system is used with three stream proportioning Hemodialysis Machines equipped with the bibag module such as the 2008T BlueStar Hemodialysis Machine and intended for use in bicarbonate hemodialysis for acute and chronic renal failure. The bibag is intended for extracorporeal bicarbonate hemodialysis according to a physician's prescription.

    Crit-Line Clip Monitor (CLiC) (Optional):

    The Crit-Line Clip Monitor is used with the 2008T BlueStar Hemodialysis Machine to non-invasively measure hematocrit, oxygen saturation and percent change in blood volume. The CLiC device measures hematocrit, percent change in blood volume and oxygen saturation in real time for application in the treatment of dialysis patients with the intended purpose of providing a more effective treatment for both the dialysis patient and the clinician. Based on the data that the monitor provides, the clinician/nurse, under physician direction, intervenes (i.e., increases or decreases the rate at which fluid is removed from the blood) in order to remove the maximum amount of fluid from the dialysis patient without the patient experiencing the common complications of dialysis which include nausea, cramping and vomiting.

    Device Description

    The 2008T Machine is an electromechanical device. Software controls the machine during hemodialysis treatment, including fluid flow, mixing, heating, and alarms. The 2008T Machine provides hemodialysis treatment by controlling and monitoring both the dialysate circuit and the extracorporeal blood circuit. The machine pumps blood from the patient's body through an extracorporeal circuit, one component of which is the dialyzer. The dialyzer contains a semi-permeable membrane that uses diffusion to transfer toxins and ultrafiltration to transport excess water from the blood into the dialysate circuit. In this separate dialysate circuit, the dialysate concentrates are mixed with purified water, heated, degassed, and delivered to the dialyzer through platinum cross-linked silicone tubing. Balancing chambers control the dialysate during treatment. During treatment, the extracorporeal blood circuit is monitored for venous and arterial blood pressures as well as for the presence of air and blood.

    AI/ML Overview

    The provided text is a 510(k) summary for the Fresenius Medical Care 2008T BlueStar™ Hemodialysis Machine. This document outlines the device description, indications for use, comparison to a predicate device, and performance data to demonstrate substantial equivalence to a legally marketed device.

    However, the information provided does not describe acceptance criteria and a study that proves a device meets those criteria in the context of an Artificial Intelligence (AI) or machine learning (ML) enabled medical device.

    The document is for a hemodialysis machine, which is an electro-mechanical device, not an AI/ML device for diagnostic or predictive purposes. The "performance data" sections are related to physical and biological safety, functional verification, and material compatibility of the hemodialysis machine itself, not validation of an AI/ML algorithm's performance on a dataset.

    Therefore, I cannot extract the requested information (table of acceptance criteria with reported device performance, sample sizes for test/training sets, data provenance, number of experts for ground truth, adjudication methods, MRMC study details, standalone performance, type of ground truth, training set size, and training ground truth establishment) as this document does not pertain to an AI/ML enabled medical device study.

    To answer your request, I would need a document describing the validation of an AI/ML medical device.

    Ask a Question

    Ask a specific question about this device

    Why did this record match?
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The DORA Disposable A.V. Fistula Needle Sets (Safety Needle Series) are single-use sterile medical devices intended to be used as vein puncture for hemodialysis treatment. Protective Shield aids in the prevention of accidental needlesticks.

    The DORA Disposable A.V. Fistula Needle Sets are single-use sterile medical devices intended to be used as vein puncture for hemodialysis treatment.

    Device Description

    The proposed device, DORA Disposable A.V. Fistula Needle Sets, is a non-implantable blood access device, which mainly consists of an adaptor, flexible tube and sharp needle. It is available in two types, 1) Needle sets with safety feature and 2) Needle sets without safety feature. Both the two types of proposed device are provided sterile and are for single use only.

    The two types of proposed devices are offered in difference configurations with options that include needle gauge, needle length, wing types (fixed wing or rotatable wing).

    The proposed device and its package are designed to be provided in Gamma sterilization. The package could maintain the sterility of the device for three years.

    The Protective Shield for injury prevention requires physical action by the clinician to activate and is designed to cover the cannula after treatment. Correct use of this safety feature will eliminate accidental needlestick injuries.

    The proposed device is used in conjunction with following hemodialysis blood tubing sets during clincial use.

    AI/ML Overview

    The provided document, a 510(k) Summary for the DORA Disposable A.V. Fistula Needle Sets, details the premarket notification of intent to market the device and its substantial equivalence to a legally marketed predicate device. This type of submission focuses on demonstrating that a new device is as safe and effective as an already approved device, rather than proving novel effectiveness through extensive clinical trials.

    As such, the document does not contain the information requested regarding acceptance criteria and a study proving a device meets those criteria in the context of:

    • A table of acceptance criteria and reported device performance for an AI/ML or diagnostic device. This document is for a physical medical device (AV fistula needle sets).
    • Sample sizes for a test set (for AI/ML validation). The testing described is for physical characteristics and biocompatibility, not for a 'test set' in the AI/ML sense.
    • Data provenance for a test set (for AI/ML validation). Not applicable to a physical medical device.
    • Number of experts and their qualifications for establishing ground truth. Not applicable.
    • Adjudication method for a test set. Not applicable.
    • Multi-Reader Multi-Case (MRMC) comparative effectiveness study. Not applicable.
    • Standalone (algorithm only) performance. Not applicable.
    • Type of ground truth used (expert consensus, pathology, outcomes data). Not applicable.
    • Sample size for training set. Not applicable.
    • How ground truth for training set was established. Not applicable.

    Instead, the document focuses on non-clinical testing and substantial equivalence to a predicate device.

    Here's what the document does provide regarding acceptance criteria and performance:

    1. Acceptance Criteria (via Standards Compliance and Performance Testing) and Reported Device Performance:

    The acceptance criteria for this device are demonstrated through adherence to various international and national standards, as well as the successful completion of specific non-clinical performance tests. The reported performance is that the device "met all design specifications" and "is similar as that of the predicate device" or "acceptable."

    Acceptance Criteria CategorySpecific Criterion/StandardReported Device Performance
    Material/Component StandardsISO/FDIS 9626:2016 (Stainless steel needle tubing)Complies with ISO/FDIS 9626:2016 (Needle Performance)
    Packaging IntegrityASTM F88/F88M - 15 (Seal Strength)Complies
    ASTM F1929 – 15 (Seal Leaks by Dye Penetration)Complies
    Biological Safety (Biocompatibility)USP (Bacterial Endotoxin Limit)Complies
    ISO 10993-3:2014 (Genotoxicity, carcinogenicity, reproductive toxicity)Complies with ISO 10993 series standards; tests performed (Cytotoxicity;
    Sensitization; Irritation sensitivity; Systemic toxicity;
    Pyrogen; Hemolysis; Thromboresistance; Partial thromboplastin time;
    Complement activation; Bacterial reverse mutation;
    Mammalian chromosome aberration; Mouse bone marrow micronucleus;
    Activated clotting time of whole blood; Platelet adhesion;
    Muscle implantation; Subchronic systemic toxicity)
    ISO 10993-4:2002 A1:2006 (Interactions with blood)Complies
    ISO 10993-5:2009 (Vitro Cytotoxicity)Complies
    ISO 10993-6:2007 (Local effects after implantation)Complies
    ISO 10993-10:2010 (Irritation and skin sensitization)Complies
    ISO 10993-11:2006 (Systemic toxicity)Complies
    ASTM F756-13 (Hemolytic Properties)Complies
    Functional/Mechanical PerformanceISO 594-1:1986 (Luer Taper - General)Complies (Female Conical Fitting Testing)
    ISO 594-2:1998 (Luer Taper - Lock Fittings)Complies (Female Conical Fitting Testing)
    ISO 10555-1:2013 (Intravascular catheters – General requirements)Complies
    Shipping/Packaging PerformanceASTM D4169-16 (Performance Testing Of Shipping Containers)Complies
    Specific Device PerformanceSimulated Use Needlestick Prevention TestingTest results demonstrated similarity to predicate device
    Needle Performance TestingTest results demonstrated similarity to predicate device
    Mechanical Testing (Wing torque, final lock, needle pushback, mechanical hemolysis)Test results demonstrated similarity to predicate device
    Tensile Strength Testing (Tube to wing pull, tube to joint, needle to cover pull, cannula to hub)Test results demonstrated similarity to predicate device
    Tubing Kinking TestTest results demonstrated similarity to predicate device
    Leakage Testing (Liquid leakage, air leakage)Test results demonstrated similarity to predicate device
    Clamp Stop TestingTest results demonstrated similarity to predicate device
    Flow Rate Testing (Also listed as an AV Fistula Needle Set Performance Test)Test results demonstrated similarity to predicate device
    Particulate Contamination Testing (Also listed as an AV Fistula Needle Set Performance Test)Test results demonstrated similarity to predicate device
    Sterility AssuranceSAL: 10-6 (Sterility Assurance Level) via Gamma SterilizationAchieved 10-6 SAL

    2. Sample sizes used for the test set and the data provenance:

    • Sample Sizes: Not explicitly stated with specific numbers (e.g., "n=X needles were tested"). The document generally states "Non clinical tests were conducted" and "The test results demonstrated...". For a 510(k) submission for a physical device, detailed sample sizes for each specific test are typically found in the full technical documentation, not summarized in the 510(k) summary as it is here.
    • Data Provenance: The tests were conducted internally by Bain Medical Equipment (Guangzhou) Co., Ltd. or by test labs they contracted. The document implicitly indicates the tests originate from China (Guangzhou) as that's the manufacturer's location. The tests are "non-clinical" and likely conducted in laboratory settings, not on patient data or retrospective/prospective human studies.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • Not applicable as this is a physical medical device. "Ground truth" in this context refers to compliance with established engineering and biocompatibility standards, not expert human interpretation for a diagnostic or AI device.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

    • Not applicable.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • No, a MRMC study was not done. This device is a physical medical instrument, not an AI/ML diagnostic tool.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • No, not applicable.

    7. The type of ground truth used (expert concensus, pathology, outcomes data, etc):

    • For physical devices, the "ground truth" is adherence to predefined engineering specifications, internationally recognized standards (ISO, ASTM, USP), and established safety and performance benchmarks (e.g., sterilization effectiveness, material strength, biocompatibility profiles). It's a truth based on physical and chemical properties and their interaction, rather than clinical outcomes or diagnostic interpretations.

    8. The sample size for the training set:

    • Not applicable. This is not an AI/ML device that uses a "training set."

    9. How the ground truth for the training set was established:

    • Not applicable.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1